{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:56:57Z","timestamp":1769605017350,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570710"],"award-info":[{"award-number":["81570710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jdiacomp.2024.108738","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T08:34:07Z","timestamp":1711528447000},"page":"108738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased glycemic variability results in abnormal differentiation of T cell subpopulation in type 2 diabetes patients"],"prefix":"10.1016","volume":"38","author":[{"given":"Qi","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Sa","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-5245","authenticated-orcid":false,"given":"Xiao-Ming","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108738_bb0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0010","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study G","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0020","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Group AC","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/nyas.12044","article-title":"Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials","volume":"1281","author":"Giorgino","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0030","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12020-018-1546-z","article-title":"Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients","volume":"60","author":"Hu","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0040","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jdi.13394","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy","volume":"12","author":"Yang","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40200-017-0323-5","article-title":"Glucose variability for cardiovascular risk factors in type 2 diabetes: a meta-analysis","volume":"16","author":"Liang","year":"2017","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12933-019-0831-3","article-title":"Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis","volume":"18","author":"Besch","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1089\/dia.2012.0099","article-title":"Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data","volume":"14","author":"Qu","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0060","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/dia.2011.0191","article-title":"Does glycemic variability impact mood and quality of life?","volume":"14","author":"Penckofer","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12020-019-02150-1","article-title":"Acute glycemic variability on admission predicts the prognosis in hospitalized patients with coronary artery disease: a meta-analysis","volume":"67","author":"Pu","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0070","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-020-01194-2","article-title":"Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes","volume":"20","author":"Wakasugi","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001923","article-title":"Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes","volume":"9","author":"Wakasugi","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0080","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jdi.13336","article-title":"Relationships between time in range, glycemic variability including hypoglycemia and types of diabetes therapy in Japanese patients with type 2 diabetes mellitus: Hyogo Diabetes Hypoglycemia Cognition Complications study","volume":"12","author":"Kuroda","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.diabres.2012.09.003","article-title":"The linkage between inflammation and Type 2 diabetes mellitus","volume":"99","author":"Cruz","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0095","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1111\/bph.13845","article-title":"Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges","volume":"174","author":"Kyaw","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0100","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.clinbiochem.2012.05.031","article-title":"Role of homocysteine in end-stage renal disease","volume":"45","author":"Wu","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0105","first-page":"1841690","article-title":"Immune cells and inflammation in diabetic nephropathy","volume":"2016","author":"Zheng","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0115","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1182\/blood-2005-05-1864","article-title":"Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo","volume":"106","author":"Siegmund","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diabres.2019.02.007","article-title":"The effect of short-term intensive insulin therapy on circulating T cell subpopulations in patients with newly diagnosed type 2 diabetes mellitus","volume":"149","author":"Cheng","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0130","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1249\/01.MSS.0000117161.66394.07","article-title":"Reliability and validity of the International Physical Activity Questionnaire (IPAQ)","volume":"36","author":"Hallal","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13613-020-0635-3","article-title":"Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis","volume":"10","author":"Chao","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004841","article-title":"Effects of the mean amplitude of glycemic excursions and vascular endothelial dysfunction on cardiovascular events in nondiabetic patients with coronary artery disease","volume":"6","author":"Akasaka","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.666008","article-title":"CGMS and glycemic variability, relevance in clinical research to evaluate interventions in T2D, a literature review","volume":"12","author":"Breyton","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0150","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/dc12-0925","article-title":"Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction","volume":"36","author":"Su","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrendo.2009.149","article-title":"Reappraising the stereotypes of diabetes in the modern diabetogenic environment","volume":"5","author":"Wentworth","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/dc10-0579","article-title":"Identification of autoantibody-negative autoimmune type 2 diabetic patients","volume":"34","author":"Brooks-Worrell","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0165","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/diabetes.50.8.1683","article-title":"Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets","volume":"50","author":"Maedler","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","article-title":"Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets","volume":"110","author":"Maedler","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0175","doi-asserted-by":"crossref","first-page":"32956","DOI":"10.1074\/jbc.M104700200","article-title":"Dual role of inflammatory stimuli in activation-induced cell death of mouse microglial cells. Initiation of two separate apoptotic pathways via induction of interferon regulatory factor-1 and caspase-11","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.158","article-title":"USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis","volume":"3","author":"Santin","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0185","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/ATVBAHA.108.165100","article-title":"T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance","volume":"28","author":"Kintscher","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/CIRCULATIONAHA.106.638379","article-title":"T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity","volume":"115","author":"Wu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/184258","article-title":"Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus","volume":"2013","author":"Pedicino","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0205","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3694957","article-title":"Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2016","author":"Qiao","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0210","doi-asserted-by":"crossref","first-page":"31484","DOI":"10.1016\/S0021-9258(18)31720-4","article-title":"Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production","volume":"269","author":"Greiner","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0220","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ni.3269","article-title":"Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants","volume":"16","author":"De Rosa","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0225","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.cell.2013.05.016","article-title":"Posttranscriptional control of T cell effector function by aerobic glycolysis","volume":"153","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jdiacomp.2024.108738_bb0230","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.imbio.2017.03.001","article-title":"T cell metabolism in metabolic disease-associated autoimmunity","volume":"222","author":"Amersfoort","year":"2017","journal-title":"Immunobiology"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T14:28:34Z","timestamp":1716128914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1056872724000643"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108738","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased glycemic variability results in abnormal differentiation of T cell subpopulation in type 2 diabetes patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108738"}}